These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 1404131)
21. Tetracyclines (TETs) inhibit the synthesis and/or activity of cartilage proteinases in vivo and in vitro. Arsenis C; Moak SA; Greenwald RA Matrix Suppl; 1992; 1():314. PubMed ID: 1480047 [No Abstract] [Full Text] [Related]
22. Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid. Ganu V; Goldberg R; Peppard J; Rediske J; Melton R; Hu SI; Wang W; Duvander C; Heinegård D Arthritis Rheum; 1998 Dec; 41(12):2143-51. PubMed ID: 9870871 [TBL] [Abstract][Full Text] [Related]
23. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis. Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines. Gu Y; Lee HM; Golub LM; Sorsa T; Konttinen YT; Simon SR Ann Med; 2005; 37(6):450-60. PubMed ID: 16203617 [TBL] [Abstract][Full Text] [Related]
26. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. Schnaper HW; Grant DS; Stetler-Stevenson WG; Fridman R; D'Orazi G; Murphy AN; Bird RE; Hoythya M; Fuerst TR; French DL J Cell Physiol; 1993 Aug; 156(2):235-46. PubMed ID: 8344982 [TBL] [Abstract][Full Text] [Related]
27. Rabbit models of arthritis: immunolocalization of matrix metalloproteinases and tissue inhibitor of metalloproteinase in synovium and cartilage. Hembry RM; Bagga MR; Murphy G; Henderson B; Reynolds JJ Am J Pathol; 1993 Aug; 143(2):628-42. PubMed ID: 8342606 [TBL] [Abstract][Full Text] [Related]
28. Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis. Boyle DL; Kowaluk EA; Jarvis MF; Lee CH; Bhagwat SS; Williams M; Firestein GS J Pharmacol Exp Ther; 2001 Feb; 296(2):495-500. PubMed ID: 11160636 [TBL] [Abstract][Full Text] [Related]
29. Tetracyclines inhibit tissue collagenases. Effects of ingested low-dose and local delivery systems. Golub LM; Goodson JM; Lee HM; Vidal AM; McNamara TF; Ramamurthy NS J Periodontol; 1985 Nov; 56(11 Suppl):93-7. PubMed ID: 3001266 [TBL] [Abstract][Full Text] [Related]
30. Tetracyclines inhibit human synovial collagenase in vivo and in vitro. Greenwald RA; Golub LM; Lavietes B; Ramamurthy NS; Gruber B; Laskin RS; McNamara TF J Rheumatol; 1987 Feb; 14(1):28-32. PubMed ID: 3033237 [TBL] [Abstract][Full Text] [Related]
31. Arthritic disease suppression and cartilage protection with glycosaminoglycan polypeptide complexes (Peptacans) derived from the cartilage extracellular matrix: a novel approach to therapy. Ghosh P; Shimmon S; Whitehouse MW Inflammopharmacology; 2006 Aug; 14(3-4):155-62. PubMed ID: 16983497 [TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes. Mäkelä M; Larjava H; Pirilä E; Maisi P; Salo T; Sorsa T; Uitto VJ Exp Cell Res; 1999 Aug; 251(1):67-78. PubMed ID: 10438572 [TBL] [Abstract][Full Text] [Related]
34. Activation and inhibition of endogenous matrix metalloproteinases in articular cartilage: effects on composition and biophysical properties. Bonassar LJ; Stinn JL; Paguio CG; Frank EH; Moore VL; Lark MW; Sandy JD; Hollander AP; Poole AR; Grodzinsky AJ Arch Biochem Biophys; 1996 Sep; 333(2):359-67. PubMed ID: 8809074 [TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinase-9 (92-kd gelatinase/type IV collagenase equals gelatinase B) can degrade arterial elastin. Katsuda S; Okada Y; Okada Y; Imai K; Nakanishi I Am J Pathol; 1994 Nov; 145(5):1208-18. PubMed ID: 7977651 [TBL] [Abstract][Full Text] [Related]
36. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762 [TBL] [Abstract][Full Text] [Related]
37. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Golub LM; Lee HM; Ryan ME; Giannobile WV; Payne J; Sorsa T Adv Dent Res; 1998 Nov; 12(2):12-26. PubMed ID: 9972117 [TBL] [Abstract][Full Text] [Related]
38. The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism. Gilbertson-Beadling S; Powers EA; Stamp-Cole M; Scott PS; Wallace TL; Copeland J; Petzold G; Mitchell M; Ledbetter S; Poorman R Cancer Chemother Pharmacol; 1995; 36(5):418-24. PubMed ID: 7543375 [TBL] [Abstract][Full Text] [Related]
39. Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically-modified analogs. Rifkin BR; Vernillo AT; Golub LM J Periodontol; 1993 Aug; 64(8 Suppl):819-27. PubMed ID: 8410621 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor. Conway JG; Wakefield JA; Brown RH; Marron BE; Sekut L; Stimpson SA; McElroy A; Menius JA; Jeffreys JJ; Clark RL J Exp Med; 1995 Aug; 182(2):449-57. PubMed ID: 7629505 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]